Title : Tandutinib, an oral, small-molecule inhibitor of FLT3 for the treatment of AML and other cancer indications.

Pub. Date : 2008 Jan

PMID : 18175263






2 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Millennium Pharmaceuticals Inc"s tandutinib (MLN-518) is an orally active inhibitor of FLT3 kinase and family members PDGFR beta and c-Kit. tandutinib platelet derived growth factor receptor beta Homo sapiens
2 Millennium Pharmaceuticals Inc"s tandutinib (MLN-518) is an orally active inhibitor of FLT3 kinase and family members PDGFR beta and c-Kit. tandutinib platelet derived growth factor receptor beta Homo sapiens